Business Context and Reporting Period
This Form 8-K Current Report was filed by CorMedix Inc. on October 26, 2021. The filing discloses a modification to the employment agreement of Matt David, M.D., the Company's Chief Financial Officer, who is serving as interim Chief Executive Officer. The Board has initiated a search for a permanent CEO.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on executive compensation adjustments.
Material Changes
The primary material change is the amendment to Dr. David's compensation package effective October 26, 2021:
- Base Salary (Interim CEO): Increased from $330,000 to $425,000 annually.
- Base Salary (Post-Interim CFO): Set at $375,000 annually (a $45,000 increase from the prior agreement).
- Target Bonus (Interim CEO): Increased from 30% to 60% of base salary.
- Target Bonus (Post-Interim CFO): Set at 40% of base salary.
- Severance: Increased from 9 months to 12 months of base salary in the event of termination without Cause or resignation for Good Reason during the interim CEO period.
- Equity Grant: Dr. David will receive a stock option for 125,000 shares, vesting over four years.
Outlook, Risks, and Management Commentary
Management commentary indicates that the Board is actively searching for a new Chief Executive Officer. The compensation adjustments are contingent on Dr. David's continued service as interim CEO. The filing notes that Dr. David has waived rights to a "Good Reason" termination specifically related to ceasing his interim CEO role. No specific financial risks or contingencies regarding the Company's operations are detailed in this document.
Key Facts for Investor Verification
- Verify the exact grant date and exercise price of the 125,000 share stock option referenced in the filing.
- Confirm the timeline for the CEO search process and any potential impact on operational continuity.
- Review the full text of the Letter Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason."
- Monitor future filings for the appointment of a permanent CEO and any subsequent compensation adjustments.